197 related articles for article (PubMed ID: 12949240)
1. The polysaccharide capsule of Cryptococcus neoformans interferes with human dendritic cell maturation and activation.
Vecchiarelli A; Pietrella D; Lupo P; Bistoni F; McFadden DC; Casadevall A
J Leukoc Biol; 2003 Sep; 74(3):370-8. PubMed ID: 12949240
[TBL] [Abstract][Full Text] [Related]
2. Encapsulation of Cryptococcus neoformans with glucuronoxylomannan inhibits the antigen-presenting capacity of monocytes.
Retini C; Vecchiarelli A; Monari C; Bistoni F; Kozel TR
Infect Immun; 1998 Feb; 66(2):664-9. PubMed ID: 9453624
[TBL] [Abstract][Full Text] [Related]
3. Direct inhibition of T-cell responses by the Cryptococcus capsular polysaccharide glucuronoxylomannan.
Yauch LE; Lam JS; Levitz SM
PLoS Pathog; 2006 Nov; 2(11):e120. PubMed ID: 17096589
[TBL] [Abstract][Full Text] [Related]
4. Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.
Retini C; Kozel TR; Pietrella D; Monari C; Bistoni F; Vecchiarelli A
Infect Immun; 2001 Oct; 69(10):6064-73. PubMed ID: 11553544
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of CD32 induces maturation of human monocyte-derived dendritic cells via NF-kappa B signaling pathway.
Bánki Z; Kacani L; Müllauer B; Wilflingseder D; Obermoser G; Niederegger H; Schennach H; Sprinzl GM; Sepp N; Erdei A; Dierich MP; Stoiber H
J Immunol; 2003 Apr; 170(8):3963-70. PubMed ID: 12682223
[TBL] [Abstract][Full Text] [Related]
6. The presence of capsule in Cryptococcus neoformans influences the gene expression profile in dendritic cells during interaction with the fungus.
Lupo P; Chang YC; Kelsall BL; Farber JM; Pietrella D; Vecchiarelli A; Leon F; Kwon-Chung KJ
Infect Immun; 2008 Apr; 76(4):1581-9. PubMed ID: 18250173
[TBL] [Abstract][Full Text] [Related]
7. Specific activated T cells regulate IL-12 production by human monocytes stimulated with Cryptococcus neoformans.
Retini C; Casadevall A; Pietrella D; Monari C; Palazzetti B; Vecchiarelli A
J Immunol; 1999 Feb; 162(3):1618-23. PubMed ID: 9973421
[TBL] [Abstract][Full Text] [Related]
8.
Bürgel PH; Marina CL; Saavedra PHV; Albuquerque P; de Oliveira SAM; Veloso Janior PHH; de Castro RA; Heyman HM; Coelho C; Cordero RJB; Casadevall A; Nosanchuk JD; Nakayasu ES; May RC; Tavares AH; Bocca AL
Mediators Inflamm; 2020; 2020():3412763. PubMed ID: 33380899
[No Abstract] [Full Text] [Related]
9. Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.
Pietrella D; Corbucci C; Perito S; Bistoni G; Vecchiarelli A
Infect Immun; 2005 Feb; 73(2):820-7. PubMed ID: 15664921
[TBL] [Abstract][Full Text] [Related]
10. Roles for CD40, B7 and major histocompatibility complex in induction of enhanced immunity by cryptococcal polysaccharide-pulsed antigen-presenting cells.
Blackstock R
Immunology; 2003 Feb; 108(2):158-66. PubMed ID: 12562324
[TBL] [Abstract][Full Text] [Related]
11. Glucuronoxylomannan of Cryptococcus neoformans exacerbates in vitro yeast cell growth by interleukin 10-dependent inhibition of CD4+ T lymphocyte responses.
Mariano Andrade R; Monteiro Almeida G; Alexandre DosReis G; Alves Melo Bento C
Cell Immunol; 2003 Apr; 222(2):116-25. PubMed ID: 12826081
[TBL] [Abstract][Full Text] [Related]
12. Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.
da Silva TA; Hauser PJ; Bandey I; Laskowski T; Wang Q; Najjar AM; Kumaresan PR
Cytotherapy; 2021 Feb; 23(2):119-130. PubMed ID: 33303326
[TBL] [Abstract][Full Text] [Related]
13. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan.
van de Wetering JK; Coenjaerts FE; Vaandrager AB; van Golde LM; Batenburg JJ
Infect Immun; 2004 Jan; 72(1):145-53. PubMed ID: 14688091
[TBL] [Abstract][Full Text] [Related]
14. Cryptococcus gattii Capsule Blocks Surface Recognition Required for Dendritic Cell Maturation Independent of Internalization and Antigen Processing.
Huston SM; Ngamskulrungroj P; Xiang RF; Ogbomo H; Stack D; Li SS; Timm-McCann M; Kyei SK; Oykhman P; Kwon-Chung KJ; Mody CH
J Immunol; 2016 Feb; 196(3):1259-71. PubMed ID: 26740109
[TBL] [Abstract][Full Text] [Related]
15. Scanning electron microscopy of encapsulated and non-encapsulated Cryptococcus neoformans and the effect of glucose on capsular polysaccharide release.
Cleare W; Casadevall A
Med Mycol; 1999 Aug; 37(4):235-43. PubMed ID: 10421858
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcus neoformans capsular polysaccharide component galactoxylomannan induces apoptosis of human T-cells through activation of caspase-8.
Pericolini E; Cenci E; Monari C; De Jesus M; Bistoni F; Casadevall A; Vecchiarelli A
Cell Microbiol; 2006 Feb; 8(2):267-75. PubMed ID: 16441437
[TBL] [Abstract][Full Text] [Related]
17. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rbeta2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells.
Vecchiarelli A; Pietrella D; Bistoni F; Kozel TR; Casadevall A
Immunology; 2002 Jun; 106(2):267-72. PubMed ID: 12047756
[TBL] [Abstract][Full Text] [Related]
18. Receptor-mediated recognition of Cryptococcus neoformans.
Levitz SM
Nihon Ishinkin Gakkai Zasshi; 2002; 43(3):133-6. PubMed ID: 12145626
[TBL] [Abstract][Full Text] [Related]
19. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
[TBL] [Abstract][Full Text] [Related]
20. T lymphocyte and monocyte interaction by CD40/CD40 ligand facilitates a lymphoproliferative response and killing of Cryptococcus neoformans in vitro.
Vecchiarelli A; Retini C; Pietrella D; Monari C; Kozel TR
Eur J Immunol; 2000 May; 30(5):1385-93. PubMed ID: 10820385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
